4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022861
CHIEF ACCOUNTING OFFICER gave up 3,084 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 480 shares (grant or award)
- CHIEF ACCOUNTING OFFICER acquired 7,265 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-07-15 | Grant or award | +480 | $15.65 | $7,512 | 22,254 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Option exercise | +6,490 | 28,744 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Shares withheld for taxes | −2,755 | $26.74 | $73,669 | 25,989 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-02 | Option exercise | +775 | 26,764 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-02 | Shares withheld for taxes | −329 | $26.74 | $8,797 | 26,435 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Grant or award · Restricted Share Unit | +9,450 | 9,450 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Grant or award · Share Option | +18,900 | 18,900 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit | −3,932 | 7,865 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit | −2,558 | 7,672 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-09-02 | Option exercise · Restricted Share Unit | −775 | 774 | D | ||
Loading xslF345X05/form4-09052024_120905.xml…